| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |